- Home
- ASTH vs OPK Comparison
ASTH vs OPK Comparison
Compare ASTH & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTH
- OPK
- Stock Information
- Founded
- ASTH 1994
- OPK 2007
- Country
- ASTH United States
- OPK United States
- Employees
- ASTH N/A
- OPK N/A
- Industry
- ASTH Professional Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ASTH Consumer Discretionary
- OPK Health Care
- Exchange
- ASTH Nasdaq
- OPK Nasdaq
- Market Cap
- ASTH 1.1B
- OPK 998.0M
- IPO Year
- ASTH N/A
- OPK 1995
- Fundamental
- Price
- ASTH $23.11
- OPK $1.36
- Analyst Decision
- ASTH Strong Buy
- OPK Buy
- Analyst Count
- ASTH 8
- OPK 5
- Target Price
- ASTH $43.00
- OPK $2.28
- AVG Volume (30 Days)
- ASTH 626.8K
- OPK 2.9M
- Earning Date
- ASTH 11-06-2025
- OPK 10-29-2025
- Dividend Yield
- ASTH N/A
- OPK N/A
- EPS Growth
- ASTH N/A
- OPK N/A
- EPS
- ASTH 0.20
- OPK N/A
- Revenue
- ASTH $2,896,452,000.00
- OPK $642,067,000.00
- Revenue This Year
- ASTH $60.87
- OPK N/A
- Revenue Next Year
- ASTH $27.04
- OPK N/A
- P/E Ratio
- ASTH $117.98
- OPK N/A
- Revenue Growth
- ASTH 68.17
- OPK N/A
- 52 Week Low
- ASTH $20.12
- OPK $1.11
- 52 Week High
- ASTH $45.16
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ASTH 39.76
- OPK 48.23
- Support Level
- ASTH $20.12
- OPK $1.24
- Resistance Level
- ASTH $24.50
- OPK $1.35
- Average True Range (ATR)
- ASTH 1.84
- OPK 0.06
- MACD
- ASTH -0.04
- OPK 0.01
- Stochastic Oscillator
- ASTH 27.36
- OPK 80.00
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.